Cellular mechanisms of nucleocytoplasmic export through Nuclear Envelope Budding
Project Number5R01GM143186-04
Contact PI/Project LeaderPARKHURST, SUSAN M
Awardee OrganizationFRED HUTCHINSON CANCER CENTER
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Transport of nucleic acids and proteins from the nucleus to the cytoplasm is essential for nearly all cellular
processes, and when mis-regulated, is associated with diseases, tumor formation/growth, and cancer
progression. Canonically, this indispensable process has been thought to occur exclusively via Nuclear
Pore Complexes, which span the nuclear envelope’s double membranes and provide a critical regulatory
step in what exits (and enters) the nucleus. Recently, Nuclear Envelope (NE-) budding was shown to
provide an alternative pathway for nuclear exit, particularly for large ribonucleoprotein (RNP) complexes
that would otherwise need to unfold/remodel to fit through the pores. In this pathway, large
macromolecule complexes are encapsulated by the inner nuclear membrane, cross the perinuclear
space, fuse with the outer nuclear membrane, and are released into the cytoplasm, a mechanism
strikingly similar to herpesvirus nuclear egress. Thus, NE-budding elegantly allows for large RNP
complexes to exit the nucleus together and be delivered as a package for specific cellular functions.
Despite its clear biological importance and clinical relevance, very little is yet known about the regulatory
or structural machineries that allow NE-budding to occur in any system. Recently, we found that the
Wiskott Aldrich Syndrome family actin nucleation protein, WASH, its four subunit regulatory complex
(SHRC), and Arp2/3 are necessary for NE-budding. Using WASH/SHRC as a new entry point, in tandem
with strategies to discover novel genes/proteins involved in this process, our long-term goal is to
understand the molecular and cellular mechanics that govern NE-budding. The specific aims of this
proposal are to determine the mechanism(s) of WASH/SHRC function in NE-budding, and to
identify/analyze the infrastructural components/machineries governing the dynamic NE-budding process
using a combination of genetic, biochemical, cell biological, time-lapse live imaging, and super-
resolution/EM microscopy approaches. Drosophila provides an excellent, genetically amenable,
organism for studying this conserved process due to its amenability for imaging and the wealth of cutting
edge cell/molecular techniques and reagents. The information gathered in these studies will help to
elucidate the mechanisms governing this exciting new nuclear export pathway in normal development or
when mis-regulated in disease conditions, and may inform the study of herpesvirus nuclear egress as
well.
Public Health Relevance Statement
PROJECT NARRATIVE
The transport of molecular complexes from the nucleus to the cytoplasm is essential for most
developmental processes and has been thought to occur only through specific openings in the nuclear
envelope/membrane. A new alternate export pathway was recently described wherein large molecular
complexes exit the nucleus by ‘budding’ through the nuclear envelope/membrane, a process that we
find requires the highly-conserved WASH subfamily of Wiskott-Aldrich Syndrome (a disease with clinical
symptoms including immune deficiency and cancer) proteins. These studies are expected to provide
new insight into the rules governing this new nuclear export pathway in normal cellular processes, the
consequences of inappropriate regulation leading to disease conditions such as laminopathies,
neurological disorders, aging, herpesvirus infections, and/or cancer onset/progression, as well as
provide a fresh basis for new potential therapeutic developments.
No Sub Projects information available for 5R01GM143186-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM143186-04
Patents
No Patents information available for 5R01GM143186-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM143186-04
Clinical Studies
No Clinical Studies information available for 5R01GM143186-04
News and More
Related News Releases
No news release information available for 5R01GM143186-04
History
No Historical information available for 5R01GM143186-04
Similar Projects
No Similar Projects information available for 5R01GM143186-04